Hypoxia-inducible factor 1 is a master regulator of breast cancer metastatic niche formation (Q35239845)

7 August 2017

Hypoxia-inducible factor 1 is a master regulator of breast cancer metastatic niche formation (English)

1 reference

7 August 2017

0 references

1 reference

12

Gregg L Semenza

1 reference

7 August 2017

11

Denis Wirtz

1 reference

7 August 2017

Carmen Chak-Lui Wong

1

1 reference

7 August 2017

Daniele M Gilkes

2

1 reference

7 August 2017

Huafeng Zhang

3

1 reference

7 August 2017

Jasper Chen

4

1 reference

7 August 2017

Hong Wei

5

1 reference

7 August 2017

Pallavi Chaturvedi

6

1 reference

7 August 2017

Stephanie I Fraley

7

1 reference

7 August 2017

Chun-Ming Wong

8

1 reference

7 August 2017

Ui-Soon Khoo

9

1 reference

7 August 2017

Irene Oi-Lin Ng

10

1 reference

7 August 2017

language of work or name

English

0 references

publication date

12 September 2011

1 reference

Proceedings of the National Academy of Sciences of the United States of America

7 August 2017

1 reference

7 August 2017

108

1 reference

7 August 2017

16369-16374

1 reference

7 August 2017

39

1 reference

A perspective on cancer cell metastasis

7 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3182724

Allosteric inhibition of lysyl oxidase-like-2 impedes the development of a pathologic microenvironment

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3182724

Se-methylselenocysteine sensitizes hypoxic tumor cells to irinotecan by targeting hypoxia-inducible factor 1alpha

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3182724

The lysyl oxidases LOX and LOXL2 are necessary and sufficient to repress E-cadherin in hypoxia: insights into cellular transformation processes mediated by HIF-1

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3182724

Defining the role of hypoxia-inducible factor 1 in cancer biology and therapeutics

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3182724

Matrix crosslinking forces tumor progression by enhancing integrin signaling

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3182724

The lysyl oxidase inhibitor, beta-aminopropionitrile, diminishes the metastatic colonization potential of circulating breast cancer cells

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3182724

Hypoxia-induced lysyl oxidase is a critical mediator of bone marrow cell recruitment to form the premetastatic niche

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3182724

Paradoxical roles for lysyl oxidases in cancer--a prospect

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3182724

Selective upregulation and amplification of the lysyl oxidase like-4 (LOXL4) gene in head and neck squamous cell carcinoma

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3182724

RETRACTED: Lysyl oxidase is essential for hypoxia-induced metastasis

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3182724

VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3182724

Levels of hypoxia-inducible factor-1alpha independently predict prognosis in patients with lymph node negative breast carcinoma

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3182724

Lysyl oxidases: a novel multifunctional amine oxidase family

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3182724

Hypoxia-inducible factor 1 is a basic-helix-loop-helix-PAS heterodimer regulated by cellular O2 tension

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3182724

Tumor hypoxia and malignant progression.

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3182724

Combination treatment of Cetuximab and photodynamic therapy in SNU-1041 squamous cancer cell line

26 September 2018

1 reference

Crossref

https://api.crossref.org/works/10.1073%2FPNAS.1113483108

Hypoxia Response Elements in the Aldolase A, Enolase 1, and Lactate Dehydrogenase A Gene Promoters Contain Essential Binding Sites for Hypoxia-inducible Factor 1

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21911388

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Differential expression of the LOX family genes in human colorectal adenocarcinomas

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21911388

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1073/PNAS.1113483108

1 reference

7 August 2017

0 references

1 reference

7 August 2017

1 reference